Zepbound 12.5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FF0D7
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,018
Award facts
- Contract value 100% obligated
- $4,018.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $4,018.20 to AmerisourceBergen Drug Corp for the supply of Zepbound 12.5 mg/0.5 mL pens on January 6, 2026, with an ultimate completion date of January 7, 2026. The contract employs firm fixed-price pricing with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor, with Cencora, Inc. (doing business as AmerisourceBergen) as its parent organization. This delivery order operates under AmerisourceBergen's significant Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026, which provides the overarching vehicle for pharmaceutical and medical supply procurement to support military healthcare programs globally.
The delivery order represents a routine pharmaceutical procurement for Zepbound, a diabetes medication, reflecting the Defense Logistics Agency's ongoing medical supply chain operations. AmerisourceBergen's extensive portfolio of federal contracts demonstrates its established capability as a critical pharmaceutical distributor for military and veteran healthcare systems, delivering a comprehensive range of brand-name and generic medications, vaccines, and specialized medical commodities across multiple therapeutic domains. This contract award exemplifies the company's role as a primary vendor supporting the Defense Health Agency and other government healthcare systems through flexible and competitive procurement mechanisms.
Quick answers
Who was awarded contract SPE2DR26FF0D7?
SPE2DR26FF0D7 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 6, 2026.
How much is contract SPE2DR26FF0D7 worth?
The government has obligated $4,018 on SPE2DR26FF0D7.
Is contract SPE2DR26FF0D7 an order under another contract?
Yes. SPE2DR26FF0D7 is a delivery order under SPE2DR25D2005, an indefinite delivery contract.
Was contract SPE2DR26FF0D7 competed?
The extent of competition for SPE2DR26FF0D7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award